CD8A and neoplasm: Notably, we demonstrated for the first time that the combination of L-TBI and localized H-RT to the primary tumor activated CD8+ T-cell dependent anti-tumor immunity, inhibited spontaneous lung metastases and retarded secondary tumor growth, all of them significantly increasing the survival of the treated mice.